Live symbol workspace

NASDAQ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for NASDAQ skewed neutral (196 of 452 scored calls). The most accurate provider on this asset is groq-llama-3.1-8b-instant at 41.0% across 444 verified calls.

Provider track record

groq-llama-3.1-8b-instant

182/444 verified calls

41.0%

Confidence trend

58%

▼ 2.7 pts vs previous week

Avg confidence across 30 calls in the last 7 days

What sources say

Neutral 196 articles

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Deep Sea Minerals Announces Application to List on the Nasdaq Capital Market; Shares up 12%

Bullish 191 articles

S&P 500, Nasdaq, Dow Jones Touch Record Highs as Trump Close to Making Decision on Iran Peace Deal

Hyperliquid Is 'Bigger Than Nasdaq,' Says ICE CEO — HYPE Eyes New Record High, While ETFs Top $100M

Dan Ives: Anthropic’s growth is 'just the tip of the sphere' for AI rally

Bearish 65 articles

THE GROWHUB LIMITED Announces Receipt of Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency

Peter Schiff: MicroStrategy’s ‘Smart’ Debt Buyback Just Torched 60% of Its Safety Net

Nasdaq and Dow Jones called lower as US and Iran exchange fire over Hormuz

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

NASDAQ News Intelligence (3701 articles)

AI-curated news influencing NASDAQ price, sentiment, and trend

Explore All NASDAQ News with AI Analysis

Stocks ⭐ FEATURED

5 months, 3 weeks ago

S&P 500 Wavers, Sitting Just Below Its Record Close

With Wall Street focused on this week’s Federal Reserve meeting, the S&P 500 began Monday’s session in striking distance of …

Impact on NASDAQ: Market impact analysis based on neutral sentiment with 57% confidence.

The S&P 500 is near its record close as investors await the Federal Reserve's meeting, … Medium (57%)

View full analysis →

Unknown 57% confidence

Stocks

5 months, 3 weeks ago

Jiuzi Holdings Inc. Announce Reverse Split Record Date

HANGZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Jiuzi Holdings Inc. (NASDAQ: JZXN; the “Company” or “JZXN”), a leading new …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 70% confidence.

Jiuzi Holdings Inc. has announced a 1-for-40 reverse stock split, which will increase the par … High (70%)

View full analysis →

Unknown 70% confidence

Stocks

5 months, 3 weeks ago

HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy

NAPLES, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), the nation's leading patient-centric healthcare …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 75% confidence.

HealthLynked Corp. has appointed Duncan McGillivray as its new Chief Operating Officer to accelerate national … High (75%)

View full analysis →

Unknown 75% confidence

Stocks

5 months, 3 weeks ago

US High Growth Tech Stocks To Watch In December 2025

As of December 2025, the U.S. stock market is experiencing a positive shift, with major indices like the Nasdaq Composite …

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 87% confidence.

The US stock market is experiencing a positive shift, with major indices nearing all-time highs … High (87%)

View full analysis →

Unknown 87% confidence

Stocks

5 months, 3 weeks ago

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market …

Impact on NASDAQ: Market impact analysis based on neutral sentiment with 70% confidence.

MediciNova announced an update on its Phase 2b/3 clinical trial of MN-166 (ibudilast) in ALS, … High (70%)

View full analysis →

Unknown 70% confidence

Stocks

5 months, 3 weeks ago

Billionaires Buy 2 Brilliant AI Stocks as the Nasdaq Bull Market Rolls Toward 2026

Meta Platforms and Alphabet can ride the Nasdaq bull market higher.

Impact on NASDAQ: Market impact analysis based on bullish sentiment with 72% confidence.

Billionaires are investing in Meta Platforms and Alphabet, indicating a positive outlook for these AI … High (72%)

View full analysis →

Unknown 72% confidence